What is TG Therapeutics's investing cash flow?

TG Therapeutics (TGTX) reported investing cash flow of -$9.86M in Q1 2026.

How has TG Therapeutics's investing cash flow changed year-over-year?

TG Therapeutics's investing cash flow increased by 23.7% year-over-year, from -$12.93M to -$9.86M.

What does investing cash flow mean?

The net cash impact of buying and selling assets and investments.

How do you interpret investing cash flow?

Negative values typically indicate growth-oriented investment, while positive values may indicate asset liquidation.

How does investing cash flow compare across companies?

Standard across all industries; reflects the company's capital deployment strategy.

TG Therapeutics TGTX Investing Cash Flow

Investing Cash Flow at other companies

BiogenBIIB

-$209.5M-343%

BridgeBio PharmaBBIO

-$42.74M-2,579%

Spyre Therapeutics, Inc.SYRE

$56.58M+92,856%

Krystal Biotech, Inc.KRYS

-$63.58M-16.1%

Arrowhead ResearchARWR

-$894.28M-113%

Roivant SciencesROIV

-$1.09B-112,409%

Other financials

Income statement

See full

Revenue$204.9M+69.6%

Gross profit$171.4M+62.8%

Operating income$34.8M+304%

Net income$19.8M+291%

EPS (diluted)$0.12+300%

Balance sheet

See full

Cash & equivalents$442.2M+235%

Total debt$753.6M+197%

Total equity$583.1M+146%

Total assets$1.5B+133%

Cash flow

See full

Operating cash flow-$17.9M+37.7%

CapEx$51.0K+104%

Free cash flow-$17.9M+37.6%

Valuation

See full

Market cap$8.15B-14.3%

Enterprise value$8.46B-11.1%

P/E17.6×-225×

P/S11.6×-13.0×

Profitability

See full

Gross margin83.1%-4.4pp

Operating margin21.3%+5.9pp

Net margin66%+55.8pp

FCF margin-6,328.4%+4,773pp

Returns & leverage

See full

Return on equity112.6%+92.9pp

Debt / equity1.3×+0.2×

Current ratio5.8×+1.8×

Where this comes from

Reported directly by TG Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The official record: TG Therapeutics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about TG Therapeutics's investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is TG Therapeutics's investing cash flow?: TG Therapeutics (TGTX) reported investing cash flow of -$9.86M in Q1 2026.
How has TG Therapeutics's investing cash flow changed year-over-year?: TG Therapeutics's investing cash flow increased by 23.7% year-over-year, from -$12.93M to -$9.86M.
What does investing cash flow mean?: The net cash impact of buying and selling assets and investments.
How do you interpret investing cash flow?: Negative values typically indicate growth-oriented investment, while positive values may indicate asset liquidation.
How does investing cash flow compare across companies?: Standard across all industries; reflects the company's capital deployment strategy.